Literature DB >> 15324737

Emerging roles of tissue factor in viral hemorrhagic fever.

Wolfram Ruf1.   

Abstract

Activation of coagulation by tissue factor (TF) is frequently observed in sepsis syndrome and is documented in certain viral hemorrhagic fevers. Coagulation protease complexes signal by activating the G-protein coupled, protease-activated receptors that regulate inflammation. Blockade of TF attenuates lethality in experimental models of Ebola virus infection but - similar to findings in bacterial sepsis - reduction of inflammation, rather than attenuation of coagulation, predicts survival of treated animals. Thus, targeting TF appears to aid the antiviral immune response in hemorrhagic fevers, and further studies are encouraged to define how TF-dependent signaling regulates immunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15324737     DOI: 10.1016/j.it.2004.07.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  17 in total

1.  Differential responses of disease-resistant and disease-susceptible primate macrophages and myeloid dendritic cells to simian hemorrhagic fever virus infection.

Authors:  Heather A Vatter; Margo A Brinton
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

2.  Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome.

Authors:  Rima Benferhat; Thibaut Josse; Benoit Albaud; David Gentien; Zeyni Mansuroglu; Vasco Marcato; Sylvie Souès; Bernard Le Bonniec; Michèle Bouloy; Eliette Bonnefoy
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

Review 3.  Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome.

Authors:  Sara C Sebag; Julie A Bastarache; Lorraine B Ware
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

4.  Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes.

Authors:  I M B Francischetti; K B Seydel; R Q Monteiro; R O Whitten; C R Erexson; A L L Noronha; G R Ostera; S B Kamiza; M E Molyneux; J M Ward; T E Taylor
Journal:  J Thromb Haemost       Date:  2006-09-26       Impact factor: 5.824

5.  Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia.

Authors:  Jasimuddin Ahamed; Frank Niessen; Toru Kurokawa; Young Kyung Lee; Gourab Bhattacharjee; James H Morrissey; Wolfram Ruf
Journal:  Blood       Date:  2007-03-01       Impact factor: 22.113

6.  Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality.

Authors:  Frank Niessen; Christian Furlan-Freguia; José A Fernández; Laurent O Mosnier; Francis J Castellino; Hartmut Weiler; Hugh Rosen; John H Griffin; Wolfram Ruf
Journal:  Blood       Date:  2009-01-13       Impact factor: 22.113

Review 7.  Evasion of interferon responses by Ebola and Marburg viruses.

Authors:  Christopher F Basler; Gaya K Amarasinghe
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 8.  Targeting clotting proteins in cancer therapy - progress and challenges.

Authors:  Wolfram Ruf; Andrea S Rothmeier; Claudine Graf
Journal:  Thromb Res       Date:  2016-04       Impact factor: 3.944

9.  PAR-1 contributes to the innate immune response during viral infection.

Authors:  Silvio Antoniak; A Phillip Owens; Martin Baunacke; Julie C Williams; Rebecca D Lee; Alice Weithäuser; Patricia A Sheridan; Ronny Malz; James P Luyendyk; Denise A Esserman; JoAnn Trejo; Daniel Kirchhofer; Burns C Blaxall; Rafal Pawlinski; Melinda A Beck; Ursula Rauch; Nigel Mackman
Journal:  J Clin Invest       Date:  2013-02-08       Impact factor: 14.808

Review 10.  Blood coagulation, inflammation, and malaria.

Authors:  Ivo M B Francischetti; Karl B Seydel; Robson Q Monteiro
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.